"HEAL together": a randomized, hybrid type 1 effectiveness-implementation trial protocol of a peer-delivered behavioral activation intervention to improve methadone treatment retention
Recommended Citation
Magidson JF, Bradley VD, Anane JS, Kleinman MB, Felton JW, Hines AC, Baskar R, Greenblatt AD, Dean D, Anvari MS, Fitzsimons H, Bennett ME, and Belcher AM. "HEAL together": a randomized, hybrid type 1 effectiveness-implementation trial protocol of a peer-delivered behavioral activation intervention to improve methadone treatment retention. Front Public Health 2025;13:1637846.
Document Type
Article
Publication Date
7-1-2025
Publication Title
Front Public Health
Abstract
BACKGROUND: Although medications exist to effectively treat opioid use disorder (OUD), treatment retention is a pressing challenge. Peer recovery specialists (PRSs) may play an important role in OUD treatment retention, yet few evidence-based interventions to support OUD retention have been developed specifically for PRS delivery. Behavioral activation is a brief, reinforcement-based intervention with empirical support for improving depression and substance use outcomes, delivered typically by specialist mental health providers. Informed by key stakeholder feedback, our team adapted a behavioral activation and problem-solving intervention for PRS delivery ("
METHODS: The trial is being conducted at a large methadone treatment program in Baltimore City, Maryland. We are enrolling 200 patients who recently initiated methadone treatment or are experiencing challenges with methadone adherence in a randomized 1:1 ratio to receive
DISCUSSION: This trial will provide insight as to whether a PRS-delivered intervention may be effective and feasible for improving methadone treatment retention and other behavioral health outcomes. If findings are promising,
CLINICAL TRIAL REGISTRATION: NCT05299515.
Medical Subject Headings
Humans; Methadone; Peer Group; Opioid-Related Disorders; Opiate Substitution Treatment; Behavior Therapy; Adult; Male; Female; Baltimore; Middle Aged; Randomized Controlled Trials as Topic
PubMed ID
40756389
Volume
13
First Page
1637846
Last Page
1637846
